Switch theme
Sign up to access all valuation multiples
Center Laboratories Inc is active in the healthcare sector. The company is engaged in the manufacture and sale of various Western medicines. The segments include: Pharmaceutical Division which includes manufacturing and sales of various Western Medicines; Biotechnology Venture Capital consists Investing in domestic and foreign biotechnology undertakings; Glac segment - Manufacture and sale of probiotic products and others. It geographically operates in Taiwan, China and Others.
1957
200
Last FY Revenue $54.0M
Last FY EBITDA -$26.1M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Center Laboratories achieved revenue of $54.0M and an EBITDA of -$26.1M.
Center Laboratories expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Center Laboratories valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $54.0M | XXX | XXX | XXX |
| Gross Profit | XXX | $25.0M | XXX | XXX | XXX |
| Gross Margin | XXX | 46% | XXX | XXX | XXX |
| EBITDA | XXX | -$26.1M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -48% | XXX | XXX | XXX |
| EBIT | XXX | $7.8M | XXX | XXX | XXX |
| EBIT Margin | XXX | 14% | XXX | XXX | XXX |
| Net Profit | XXX | -$36.8M | XXX | XXX | XXX |
| Net Margin | XXX | -68% | XXX | XXX | XXX |
| Net Debt | XXX | $169M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Center Laboratories's stock price is TWD 40 (or $1).
Center Laboratories has current market cap of TWD 29.1B (or $970M), and EV of TWD 32.2B (or $1.1B).
See Center Laboratories trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $970M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Center Laboratories has market cap of $970M and EV of $1.1B.
Center Laboratories's trades at 19.9x EV/Revenue multiple, and -41.2x EV/EBITDA.
Equity research analysts estimate Center Laboratories's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Center Laboratories's P/E ratio is not available.
See valuation multiples for Center Laboratories and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $970M | XXX | $970M | XXX | XXX | XXX |
| EV (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 19.9x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -41.2x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 137.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -26.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 137.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCenter Laboratories's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Center Laboratories's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Center Laboratories's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Center Laboratories and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -48% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 32% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Center Laboratories acquired XXX companies to date.
Last acquisition by Center Laboratories was XXXXXXXX, XXXXX XXXXX XXXXXX . Center Laboratories acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Center Laboratories founded? | Center Laboratories was founded in 1957. |
| Where is Center Laboratories headquartered? | Center Laboratories is headquartered in Taiwan. |
| How many employees does Center Laboratories have? | As of today, Center Laboratories has 200 employees. |
| Is Center Laboratories publicy listed? | Yes, Center Laboratories is a public company listed on ROCO. |
| What is the stock symbol of Center Laboratories? | Center Laboratories trades under 4123 ticker. |
| When did Center Laboratories go public? | Center Laboratories went public in 2003. |
| Who are competitors of Center Laboratories? | Similar companies to Center Laboratories include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Center Laboratories? | Center Laboratories's current market cap is $970M |
| Is Center Laboratories profitable? | Yes, Center Laboratories is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
